caprylates has been researched along with Shock in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greiner, C; Hörnig, C; Pergola, C; Rossi, A; Sautebin, L; Schubert-Zsilavecz, M; Steinhilber, D; Werz, O; Zettl, H | 1 |
| Daniel, AM; MacLean, LD; Pierce, CH; Shizgal, HM | 1 |
2 other study(ies) available for caprylates and Shock
| Article | Year |
|---|---|
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Caprylates; Carrageenan; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mice; Neutrophils; Nuclear Envelope; Platelet Activating Factor; Pleurisy; Protein Transport; Pyrimidines; Rats; Rats, Wistar; Shock | 2011 |
Protein and fat utilization in shock.
Topics: Animals; Caprylates; Carbon Dioxide; Cardiac Tamponade; Dogs; Endotoxins; Escherichia coli; Fatty Acids, Nonesterified; Female; Humans; Oxidation-Reduction; Oxygen Consumption; Proteins; Shock; Shock, Septic; Urea | 1978 |